Shanghai Microport Endovascular Medtec(Group) Co.,Ltd.’s Net Profit Rose 1.2% in First Quarter of 2023

Shanghai Microport Endovascular Medtec(Group) Co.,Ltd. (上海微创心脉医疗科技(集团)股份有限公司) (688016.SH) reported a net profit of 123.6 million yuan in the first quarter of 2023, up 1.2% year-on-year.

Meanwhile, the company posted 285.6 million yuan in revenue, up 10.7% year-on-year.

At the end of the reporting period, it had 2.2 billion yuan in total assets and 288.4 million yuan in total liabilities, with a liability-to-asset ratio of 13.4%.